The Next Evolution in Public Treasuries
MicroStrategy proved the model with BTC. Now a NASDAQ-listed firm is running it with BNB, yield, and 290M users. $368M locked in.
Here's How Much $100 Invested In Masimo 10 Years Ago Would Be Worth Today
Masimo (NASDAQ: MASI) has outperformed the market over the past 10 years by 1.12% on an annualized basis producing an average annual return of 13.99%. Currently, Masimo has a market capitalization of $7.72 billion.
South Korea Pours More Cold Water On Trump's $350 Billion Deal, Seoul's Top Security Advisor Says Given US Track Record Currency Swap 'Won't Be Easy'
South Korea's national security chief, Wi Sung-lac, struck a cautious note on Monday, expressing concerns that securing a bilateral currency swap agreement with the United States would be hard to come by.
Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
Cathie Wood, Dan Ives Align On These 11 AI Stock Picks — Some Might Surprise You
Cathie Wood and Dan Ives have 11 stocks in common across ETFs. A look at the AI stocks the two key figures are betting on.
Raytheon Scores $5 Billion Coyote Missile Contract as Trump Pushes $1 Trillion Defense Budget
The U.S. Department of Defense (DOD) has awarded Raytheon Co. (NYSE: RTX) a massive $5.04 billion contract for the Coyote Missile System.
Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad
A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.
Cracker Barrel expects weaker sales and restaurant traffic after logo controversy
Cracker Barrel said Wednesday it expects lower sales and weaker customer traffic in the coming year as the continues to play out.
Bill Gates Backs Utah Geothermal Plant As Fervo Energy Targets 500 MW Capacity At Cape Station
Bill Gates and Breakthrough Energy support Fervo Energy's Cape Station project, aiming to generate 500 MW of geothermal power.
Elon's $25 Trillion Confession - Ad
Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.
US To Impose $100,000 Annual Fee On H-1B Visas As Analysts Warn Trump Risks 'Taxing Away' America's Innovation Edge
The Trump administration's plan to impose a $100,000 annual fee on H-1B visas could reshape tech hiring, strain talent pipelines from India and China, and risk driving innovation overseas, analysts warn.
Redwire Expands With New Space Defense Facility In Albuquerque
Redwire Corp (RDW) shares rose after announcing the opening of a 15,000 sq ft facility in Albuquerque to accelerate development of space-based defense systems.
We've Seen This Before... and It Didn't End Well - Ad
Strange events are unfolding in the global financial system. A monetary reset dubbed the "Mar-a-Lago Accord" is quietly in motion, and the financial elite are already taking protective action. If history is any guide, you could lose up to 40% of your wealth in the next two years. Move your money before it's too late.
3 Gold Mining Stocks Shine As Prices Hit Records
Gold mining stocks Anglogold Ashanti, Coeur Mining, and New Gold join the top 10% for quality as gold prices hit fresh highs.
Business News Digest
AP Business Digest
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Johnson & Johnson's Tecvayli-Darzalex Combo Shows 100% Response In Newly Diagnosed Myeloma Patients
Johnson & Johnson's Tecvayli-Darzalex regimen showed 100% response rates and high MRD negativity in newly diagnosed multiple myeloma patients.
New York City's Wealthiest Neighborhoods Witness 60% Rent Surge Since Pandemic
House rental rates in some of the wealthiest neighborhoods of New York City have surged by over 60% since the COVID-19 pandemic began, putting even high-income earners in a tight spot.
The Next Evolution in Public Treasuries - Ad
MicroStrategy proved the model with BTC. Now a NASDAQ-listed firm is running it with BNB, yield, and 290M users. $368M locked in.
Opendoor Chairman Keith Rabois Calls Company 'Bloated,' Says Only 200 Of 1,400 Employees Needed: Promises Merit-Driven Overhaul
Returning to OPEN board as chairman, Keith Rabois plans to cut 85% of the workforce and revamp culture. Tech layoffs surge amid AI push.
Ukrainian drones strike one of Russia's top oil refineries, sparking fire
Ukrainian drones overnight struck one of Russia’s largest oil refineries, sparking a fire, according to Russian officials and Ukraine’s military.
Digital Gold. Digital Oil. Digital Infrastructure. - Ad
Bitcoin and Ethereum had their turn. Now a NASDAQ-listed firm is scaling BNB, which fuels 290M users and pays yield.
Ford is moving its world headquarters for the first time in 7 decades to a new campus 3 miles away
DEARBORN, Mich. (AP) — Ford Motor Co. is taking a drive down the road in a couple of months.
Warner Bros, Oracle, And Micron Technology Are Among The Top 10 Large-Cap Gainers Last Week (Sep. 8 - Sep. 12): Are The Others In Your Portfolio?
Deal buzz, analyst upgrades, and AI momentum drove top weekly gainers—led by Warner Bros., Oracle, and Micron—across large-cap tech and media.
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
Trump's Immigration Policies Could 'Shrink' GDP Growth As US Population Projected To Decline, Warns CBO
The U.S. population growth is expected to decline at a faster rate than previously projected due to President Donald Trump's immigration policies, according to the Congressional Budget Office (CBO).
FanDuel agrees to pay Jaguars roughly $5M to offset losses from ex-employee's theft, AP source says
JACKSONVILLE, Fla. (AP) — FanDuel has agreed to pay the Jacksonville Jaguars roughly $5 million to help offset the nearly $20 million that a and deposited at the sportsbook, a person familiar with discussions said Friday.
Why Trump's "Smart Dollar" Could Rewrite the Rules - Ad
Congress just approved President Trump's latest plans for the dollar - and they're so bold that one central bank chair says we haven't seen anything like it in almost a century. Our Wall Street insider says it's the start of a once-in-a-lifetime investing opportunity, IF you act now.
Fed Governor Lisa Cook claimed 2nd residence as 'vacation home,' undercutting Trump fraud claims
WASHINGTON (AP) — Federal Reserve Governor Lisa Cook referred to a condominium she purchased in June 2021 as a “vacation home" in a loan estimate, a characterization that could undermine claims by the Trump administration that she committed mortgage fraud.
Opendoor Is A 'Stock That Could Be The Amazon Of Housing': Eric Jackson
Eric Jackson sees Opendoor as able to simplify the experience of buying and selling a home in the same way that Amazon revolutionized retail.
The First Public Cash-Flowing Digital Treasury - Ad
Unlike Bitcoin vaults, this NASDAQ-listed company earns yield through BNB staking and nodes. $368M already deployed, still overlooked.
New England's shrimp industry is struggling, with fishermen catching few in 2025
PORTLAND, Maine (AP) — There's an effort underway to bring New England shrimp back to seafood customers — but fishermen have found few of the crustaceans, and the fishing industry that harvests them may face an even longer shutdown.
Lennar Shares Are Trading Lower Friday: What's Going On?
Lennar shares are trading lower Friday after the company reported worse-than-expected third quarter financial results on Thursday after the market closed.
Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
Peter Schiff Blames Fannie Mae And Freddie Mac For Skyrocketing Home Prices: 'By Inflating Demand, They Jack Up Prices,' Leading To A 'Debt Trap'
Economist Peter Schiff criticized America's two most prominent housing finance institutions, blaming them for the current housing affordability crisis.
Now summer's over, here's what to do with all those photos on your camera roll
LONDON (AP) — The summer holidays are over, and all those great times you had on vacation have been memorialized in hundreds of smartphone photos. Now what?
Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad
A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.
Elon Musk's Grim Warning At UK Far-Right Rally Sparks Controversy: 'Violence Is Coming, Fight Back, or Die'
Elon Musk has issued a stark warning at a far-right rally in the UK, forecasting an impending wave of violence.
Stock Market Today: Dow, S&P 500 Futures Slip—Adobe, Warner Bros, Super Micro In Focus
U.S. stock futures declined on Friday following Thursday's rally. Futures of major benchmark indices were lower.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.